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Background: Cardiopulmonary bypass induces oxidative stress and a whole-
body inflammatory reaction that are believed to increase surgical morbidity.
Objectives: Our goal was to investigate the effect of nitric oxide supplemen-
tation on bypass-induced oxidative stress and inflammatory reaction in
patients with and without diabetes undergoing elective coronary bypass graft
surgery.
Methods: Patients with and without diabetes were randomized to receive an
infusion of saline solution or the nitric oxide donor nitroglycerin at 1 µg ·
kg–1 · min–1 starting 10 minutes before the initiation of cardiopulmonary
bypass and then maintained for 4 hours (n = 10 per group). Serial blood sam-
ples were taken at various intervals and plasma was analyzed for markers of
oxidative stress (lipid hydroperoxides, protein carbonyls, and protein nitroty-
rosine) and inflammation (complement C3a, elastase, interleukin 8, and
tumor necrosis factor α).
Results: Cardiopulmonary bypass significantly increased lipid hydroperox-
ides, protein carbonyls, protein nitrotyrosine, complement C3a, elastase, sol-
uble E-selectin, interleukin 8, and tumor necrosis factor α in both groups.
Infusion of nitroglycerin significantly reduced the increase in lipid hydroper-
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T he use of cardiopulmonary bypass (CPB) in cardiacsurgery induces a systemic inflammatory reaction
and oxidative stress that is believed to result in
increased postoperative morbidity and hospital stay.1
Diabetes mellitus is an independent risk factor for early
postoperative mortality and complications after bypass
graft surgery,2,3 although the reason for this heightened
risk is unclear. One possibility may be the presence of
a greater oxidative stress. Indeed, it has been suggested
that nitric oxide (NO) and superoxide anion levels are
already elevated in persons with diabetes under basal
conditions.4 The reaction between NO and superoxide
anions results in the formation of the potent oxidant
peroxynitrite (ONOO-),5 a factor that may exacerbate
oxidative stress in patients with diabetes. Peroxynitrite
is also a major source of hydroxyl radicals that are
known to cause severe cellular injury and death.6 NO
donors are regularly used during and after CPB to con-
trol the patient’s hemodynamics, but the effect of
exogenous NO on oxidation in clinical conditions is
unknown.
Another possible explanation for the greater surgical
risk associated with diabetes is an altered inflammato-
ry response to CPB. This thesis may be supported by
the evidence that patients with diabetes are predisposed
to increased surgical wound infections7; however, to
the best of our knowledge, the medical literature con-
tains no information on the subject. In this article, we
speculate that exogenous NO may affect the inflamma-
tory response to CPB since (1) inhalation of NO
reduces the production of interleukin 8 (IL-8) and inter-
leukin 6 (IL-6) in alveolar neutrophils from patients
with adult respiratory distress syndrome8 and (2)
inhaled NO modulates the leukosequestration induced
by tumor necrosis factor α (TNF-α) and the IL-8
release in guinea pig airways.9
The present study was designed to identify the type
and degree of oxidative stress and inflammatory
response induced by CPB in patients with diabetes
compared with patients without diabetes and to investi-
gate the effects of clinical administration of exogenous
NO on these reactions.
Patients and methods
The study was carried out between 1997 and 1998 and was
approved by the research ethics committee of our local health
authority. Informed written consent was obtained from all
participating patients.
Study groups and selection criteria. A total of 172
patients were operated on by one surgeon (M.G.) within the
period of the study. Patients with ventricular aneurysm, heart
failure, valvular disease, and poor left ventricular function
were excluded from the study. Only 92 patients, all undergo-
ing elective coronary bypass graft surgery, met the selection
criteria, and 40 of these patients (both with and without dia-
betes) consented to take part in the study. The patients were
blinded as to the mode of treatment, and data from all the
patients were included in the final analysis. Patients (both
with and without diabetes) were assigned numbers, and a
computer random number generator was used to create 2
groups. One group received physiologic saline solution and
the other received the NO-donor nitroglycerin (GTN) infused
at a rate of 1 µg · kg–1 · min–1 for 4 hours, starting 10 minutes
before the initiation of CPB. Administration of aspirin was
discontinued at least 7 days before the operation.
Anesthesia. All the patients received morphine (10 mg)
and prochlorperazine (12.5 mg) administered intramuscular-
ly at least 1 hour before the operation. Central venous and
radial artery cannulas were inserted with the aid of local anes-
thesia (1% lidocaine) and sedation with midazolam (3-4 mg
intravenously). Anesthesia was induced by infusion of propo-
fol (8 mg · kg–1 · h–1 intravenously) and by the administration
of fentanyl (1 mg intravenously) and pancuronium (12 mg
intravenously). Anesthesia was then maintained by continu-
2 Matata and Galiñanes The Journal of Thoracic and
Cardiovascular Surgery
July 2000
oxides and protein carbonyls in patients who have diabetes without affect-
ing levels in patients without diabetes. Nitroglycerin infusion markedly
reduced protein nitrotyrosine and tumor necrosis factor α levels in both
groups. In contrast, nitroglycerin infusion significantly increased C3a in
patients without diabetes and increased elastase and interleukin 8 levels in
patients with diabetes.
Conclusions: Cardiopulmonary bypass induces a greater oxidative stress in
patients with diabetes than in those without diabetes, and the inflammatory
reaction is qualitatively different in the 2 groups of patients. In addition,
nitroglycerin reduces oxidative stress in patients with diabetes and differen-
tially affects the inflammatory response to bypass both in patients with and
in those without diabetes. The results have important implications with
respect to the use of nitric oxide donors during cardiopulmonary bypass. (J
Thorac Cardiovasc Surg 2000;120:1-11)
ous infusion of propofol (4 mg · kg–1 · h–1 intravenously).
Hypotension was controlled by intravenous infusion of fluids
or 0.5 mg of metaraminol with increments where appropriate.
Heparin (300 IU/kg) was administered in all study patients
before CPB to achieve an activated clotting time greater than
450 seconds. A further 5000 IU of heparin was given in the
CPB prime for the CPB group. Heparin was reversed after
CPB by the administration of protamine (3 mg/kg).
Patients were sedated with propofol (1.5-2 mg · kg–1 · h–1
intravenously) while in the intensive care unit until their
core temperature was higher than 36°C and bleeding
through the chest drains was less than 50 mL/h. Then if the
blood PO2 level was greater than 75 mm Hg and the fixed
inspired oxygen fraction (FIO2) was 40% or less, the rate of
propofol infusion was reduced. When the patient was able
to respond coherently to simple instructions, propofol was
discontinued and the trachea extubated. Morphine (5 mg
intravenously) and diclofenac (100 mg intravenously), a
nonsteroidal, nonnarcotic drug, were given to treat pain
when required.
Surgical procedure. A standard CPB technique and medi-
an sternotomy were used. The CPB circuit was composed of
a roller pump (Stöckert Instrumentation, Munich, Germany),
a hollow-fiber polypropylene oxygenator with an incorporat-
ed cardiotomy reservoir (Cobe CML, Cobe Laboratories,
Gloucester, United Kingdom), and plasticized polyvinyl
chloride tubing. The pump was primed with 1.4 L of
Hartmann solution, with a flow rate of 2.0 L · min–1 · m–2
body surface area and a hypothermic temperature of 32°C
maintained throughout CPB. Coronary bypass grafting was
performed with intermittent ischemia achieved by cross-
clamping the aorta followed by fibrillation without the use of
cold cardioplegic solution.
Blood sampling. Blood samples were collected at different
times: before the induction of anesthesia, before the initiation
of CPB and coronary artery clamping (time 0), and 0.5, 1, 2,
4, 8, 24, and 48 hours thereafter. Blood samples were col-
lected into sterile tubes in 3 aliquots containing potassium
ethylenediaminetetraacetic acid (EDTA). An aliquot of blood
in EDTA tubes was used for total leukocyte counts.
Circulating leukocytes were counted by an automatic cell
counter (Cell-Dyn 610; Sequoia-Turner, Mountain View,
Calif). The other aliquots were centrifuged immediately at
1500g for 12 minutes at 4°C. The resultant plasma was divid-
ed into aliquots and stored at –80°C until analysis.
Measurement of NO. The plasma was assayed for the sta-
ble end products of NO, nitrite and nitrate (NOx), by the
Griess reaction method with kits from Cayman Chemical Co
(Ann Arbor, Mich). The resultant NOx levels were corrected
by plasma creatinine concentration to minimize the influence
of changes in renal excretory function,10 and the values were
expressed as micromoles per millimole of creatinine. Plasma
creatinine concentration was determined with a kit from
Sigma Chemicals (Poole, Dorset, United Kingdom).
Assessment of oxidative stress and protein nitration.
Lipid hydroperoxides, protein carbonyls, and protein
nitrotyrosine levels were determined in plasma and served
as indices of oxidative stress. Plasma lipid hydroperox-
ides11 and protein carbonyls12 were determined as previ-
ously described. Protein nitrotyrosine was determined by
an enzyme-linked immunosorbent assay (ELISA) method
also described previously.13
Assessment of the inflammatory reaction. The inflam-
matory reaction was assessed by examining the blood
leukocyte count, the degree of activation of complement
and neutrophils, and the plasma levels of the proinflamma-
tory cytokines TNF-α and IL-8. Activation of complement
was determined by the measurement in plasma of comple-
ment C3a by means of a sandwich ELISA (Quidel, San
Diego, Calif). Activation of neutrophils was determined by
the measurement of plasma elastase in complex with α1-
proteinase by means of an ELISA previously described.14
An interassay and intra-assay variability of less than 8%
was considered acceptable. The plasma levels of TNF-α
and IL-8 were quantified by means of commercially avail-
able sandwich ELISAs (Pharmingen, San Diego, Calif).
Soluble E-selectin and thrombomodulin in plasma were
determined as markers of endothelial activation and
endothelial injury, respectively,15,16 by sandwich ELISAs
for soluble E-selectin (Amersham International Inc,
Amersham, United Kingdom) and thrombomodulin
(Diagnostica Stago, Asniéres-Sur-Seine, France).
Clinical outcome. The time of mechanical ventilatory sup-
port, postoperative blood loss, and transfusion requirements
(blood transfusion was performed when hemoglobin values
fell below 10 mg/dL), the presence of postoperative fever
(defined as a tympanic temperature ≥ 37.5°C and maintained
for ≥ 24 hours), and the length of hospitalization were record-
ed. Patients were discharged from the hospital when they
were apyrexic, in an overall satisfactory stable condition, and
able to perform basic routine tasks.
Statistical analysis and expression of results. Descriptive
data were presented as mean ± SD and nondescriptive data as
mean ± SEM. Descriptive data with a skewed distribution
were presented as median and quartiles. Analysis of variance
for repeated measurements was used to compare the outcome
parameters measured in series, that is, between-subjects
effect (whether mean values vary by group), group time-
response curve (whether values in groups change in different
ways), and the time-trend effect (whether values change with
time). This allowed us to evaluate the interaction between the
CPB, diabetes, and NO effects. All the data were logarithm-
transformed before analysis to minimize skewness. The data
(normal distribution) determined only once during the exper-
iment were analyzed for differences between the 2 groups by
means of analysis of variance for nonrepeated measurements.
The Mood median test was used to compare data measured
once and also judged to be skewed. Tests were carried out at
a 5% level of statistical significance with the SPSS statistical
package (SPSS Inc, Chicago, Ill). Hemodilution occurs dur-
ing CPB. So that we could correct for this, all values for
inflammatory factors and oxidative stress markers were
expressed relative to the protein content as previously
described.17
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Results
In the groups with diabetes, the ratios of patients with
insulin-dependent and non–insulin-dependent diabetes
were 5:5 and 4:6 in the saline- and GTN-treated groups,
respectively. There were no significant differences
between patients with insulin-dependent and those with
non–insulin-dependent diabetes for all the results
obtained. Thus, for the sake of simplicity, the data are
presented together for each of the groups.
Clinical outcome. The clinical characteristics and
operative data are shown in Tables I and II. They
demonstrate that these were similar in all study groups.
No hospital mortality, neurologic accidents, or myocar-
dial infarctions occurred in the 4 study groups. The
mean time of mechanical ventilatory support was not
significantly different among the groups, and the total
postoperative blood loss, the mean values for blood
transfusion, and the incidence of postoperative fever
were also similar in all the groups. However, patients
treated with GTN were discharged from the hospital an
average of 2 days earlier than those without GTN,
although the overall difference between the groups did
not achieve a statistical significance (P = .08). A mod-
est but significant increase in blood leukocyte count
4 Matata and Galiñanes The Journal of Thoracic and
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Table I. Patients’ clinical characteristics (n = 10/group)
No diabetes Diabetes
Saline solution GTN Saline solution GTN P value
Age (y) 70.1 ± 8.2 68.9 ± 11.1 65.3 ± 6.9 64.1 ± 10.8 .09
Male/female ratio 8:2 9:1 8:2 8:2 .9
Angina class (CCS) 2.7 ± 0.6 2.9 ± 0.6 3.0 ± 0.9 2.9 ± 0.6 .9
Hypertension (No. of patients) 6 4 4 5 .8
Ratio of diseased vessels (1/2/3) 0/4/6 1/0/9 0/3/7 0/1/9 .6
Data are expressed as mean ± SD. CCS, Canadian Cardiovascular Society; GTN, nitroglycerin. 
Table II. Perioperative and postoperative data (n = 10/group)
No diabetes Diabetes
Saline solution GTN Saline solution GTN P value
No. of grafts/patient 2.7 ± 0.6 3.3 ± 0.9 3.0 ± 0.6 3.1 ± 0.9 .4
Ischemic time (min) 36.8 ± 13.3 44.6 ± 20.8 44.1 ± 12.0 47.4 ± 26.6 .08
CPB time (min) 81.5 ± 33.2 91.8 ± 35.1 88.2 ± 24.0 92.4 ± 35.1 .07
Ventilatory support (h) 7.1 ± 4.4 7.1 ± 3.5 8.1 ± 6.0 6.9 ± 3.2 .9
Postoperative blood loss (mL) 468 (413, 674) 595 (507, 702) 462 (301, 966) 600 (458, 1117) .3
Blood transfusion (mL) 0 (0, 700) 350 (0, 700) 350 (0, 788) 525 (0, 1050) .8
Postoperative fever (No. of patients) 3 5 6 4 .6
Hospital stay (d) 6.7 ± 2.2 4.5 ± 1.3 7.9 ± 5.1 5.0 ± 0.9 .08
The data for blood loss and blood transfusion were expressed as median and quartiles with statistical significance determined by the Mood median test. The rest of
the data were expressed as mean ± SD. CPB, Cardiopulmonary bypass; GTN, nitroglycerin.
Table III. Plasma NOx values (micrograms per micromole of creatinine) during and after cardiac surgery (n =
10/group)
No diabetes Diabetes
Time of sampling (h) Saline solution GTN Saline solution GTN
Before anesthesia 525 ± 89 440 ± 66 1011 ± 126 1265 ± 137
Before CPB (time 0) 881 ± 88 688 ± 82 1642 ± 250 1091 ± 187
0.5 h after CPB start 890 ± 108 639 ± 120 2097 ± 391 1717 ± 209
1 h after CPB start 648 ± 103 647 ± 91 3115 ± 544 1246 ± 88
2 h after CPB start 878 ± 144 578 ± 94 1686 ± 533 1040 ± 135
4 h after CPB start 814 ± 142 684 ± 101 1260 ± 110 1517 ± 228
8 h after CPB start 706 ± 96 688 ± 132 921 ± 139 1539 ± 173
24 h after CPB start 789 ± 115 840 ± 165 1163 ± 96 1697 ± 310
48 h after CPB start 527 ± 85 700 ± 134 1091 ± 148 1359 ± 172
The data were expressed as mean ± SEM. CPB, Cardiopulmonary bypass; GTN, nitroglycerin. 
was observed for the first 4 postoperative days both in
patients without diabetes and in those with diabetes
when compared with the values seen before anesthesia
(P = .02). GTN infusion had no significant effect on
leukocyte count (P = .85) in either group of patients.
Plasma NOx. As shown in Table III, the plasma
mean values of NOx before anesthesia were almost 2-
fold greater in patients with diabetes than in those with-
out diabetes. Anesthesia and surgical trauma increased
NOx levels in both groups (P = .01 in patients without
diabetes and P = .02 in patients with diabetes); howev-
er, whereas CPB did not induce any further increase in
NOx levels in patients without diabetes, values were 3-
fold greater in patients with diabetes. Interestingly,
GTN infusion significantly blunted the increase in
NOx plasma levels in patients with diabetes (P = .003).
Oxidative stress. As shown in Fig 1, A and B, lipid
hydroperoxide levels were increased by CPB and
changed over time (P < .001), with mean values greater
in patients with diabetes than in those without diabetes (P
= .002). They also show that although GTN infusion sig-
nificantly decreased mean lipid hydroperoxide levels in
patients with diabetes (P = .01), it did not alter mean val-
ues in those without diabetes (P = .4). In addition, the
time-response curve of lipid hydroperoxides was signifi-
cantly altered by GTN infusion (P = .03) in patients with
diabetes but not in those without diabetes (P = .9).
Fig 2, A and B shows that CPB induced an overall sig-
nificant (P < .001) increase in the mean values of protein
carbonyls in both groups of patients. A greater produc-
tion of protein carbonyls was observed in patients with
diabetes than in those without diabetes (P = .001).
Again, GTN infusion did not alter (P = .9) the CPB-
induced increase in protein carbonyls in patients without
diabetes but significantly (P = .002) reduced its forma-
tion in patients with diabetes, an effect that was achieved
without affecting the time-response curve (P = .8).
Fig 3, A and B shows that anesthesia and the surgical
trauma increased protein nitrotyrosine formation in
both groups and that further similar increases and time-
course profiles were induced by CPB (P < .001). In
contrast to the above results, GTN infusion significant-
ly blunted the formation of protein nitrotyrosine in
patients without diabetes (P = .03) and in patients with
diabetes (P = .001).
Inflammatory factors 
Complement activation. Plasma complement C3a, a
product of complement activation, increased on the
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Fig 1. Plasma lipid hydroperoxides before, during, and after
coronary bypass graft surgery in patients without diabetes
(A) and in those with diabetes (B) receiving saline solution or
nitroglycerin (GTN). Values are expressed as means of 10
patients per group and bars represent SEM. 
B
A
Fig 2. Plasma protein carbonyls before, during, and after
coronary bypass graft surgery in patients without diabetes
(A) and in those with diabetes (B) receiving saline solution or
nitroglycerin (GTN). Values are expressed as means of 10
patients per group and bars represent SEM.
B
A
institution of CPB (P < .001) in both groups (Fig 4, A
and B). However, in patients without diabetes, C3a lev-
els increased gradually (P < .001) after the initiation of
CPB and peaked by 1 hour, so that values were 12-fold
greater than those observed before anesthesia; by con-
trast, in patients with diabetes, the increase was faster
(P < .001) and greater (P < .001) than in patients with-
out diabetes. Importantly, GTN infusion greatly
increased C3a mean values in patients without diabetes
(P < .001) to a degree similar to that seen in patients
with diabetes, whereas its profile was unaffected in
patients with diabetes (P = .8).
Neutrophil activation. Plasma elastase values shown
in Fig 5, A and B, were significantly (P < .001) elevat-
ed both in patients without and in those with diabetes
for up to 4 hours after the initiation of CPB. However,
after this time values returned to within the preanesthe-
sia range in patients without diabetes, whereas they
remained elevated in patients with diabetes (P = .02).
GTN infusion had no significant effect on either the
mean elastase values (P = .9) or its time-response curve
(P = .2) in patients without diabetes. In contrast, GTN
markedly increased mean elastase values (P = .03) and
also substantially altered the profile of the time-
response curve (P = .01) in patients with diabetes.
Cytokines. Fig 6, A and B shows that the release of
IL-8 induced by CPB was significantly greater in
patients without than in patients with diabetes (P <
.001). GTN infusion significantly reduced IL-8 mean
values (P < .001) and altered the IL-8 time-response
curve (P = .04) in patients without diabetes, but again,
it increased IL-8 levels (P = .004) and altered its time-
response curve (P = .03) in patients with diabetes.
Fig 7, A and B, shows that CPB induced a substantial
increase in plasma TNF-α in patients without diabetes
that lasted for the duration of the study (P < .001) and
only a moderate but significant increase limited to the
first hour in patients with diabetes (P = .018). The effect
of GTN infusion on TNF-α release contrasts with that
observed on IL-8 in that GTN completely suppressed
the rise in TNF-α both in patients without diabetes (P <
.001) and in those with diabetes (P < .001).
Endothelial activation. The plasma mean values of
soluble E-selectin, an index of endothelial activation,
6 Matata and Galiñanes The Journal of Thoracic and
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Fig 3. Plasma protein nitrotyrosine before, during, and after
coronary bypass graft surgery in patients without diabetes
(A) and in those with diabetes (B) receiving saline solution or
nitroglycerin (GTN). Values are expressed as means of 10
patients per group and bars represent the SEM.
B
A
Fig 4. Plasma complement C3a before, during, and after
coronary bypass graft surgery in patients without diabetes
(A) and in those with diabetes (B) receiving saline solution or
nitroglycerin (GTN). Values are expressed as means of 10
patients per group and bars represent the SEM.
B
A
were modestly but significantly increased 8 hours after
the initiation of CPB both in patients without and in
those with diabetes (Fig 8, A and B, P < .001). GTN
infusion had no significant effect on the mean soluble
E-selectin (P = .8) or on the group time-response curve
(P = .13) in patients without diabetes; in contrast, a 3-
fold increase (P = .03) was observed by 8 hours after
the initiation of CPB in patients with diabetes and sig-
nificantly altered its time-response curve (P = .01).
Endothelial injury. Fig 9, A and B shows that the
mean plasma values of thrombomodulin, an index of
endothelial injury, increase with time after the initiation
of CPB both in patients without diabetes and in those
with diabetes (P = .005 in both instances) and that the
release profiles are not affected by GTN infusion in the
2 groups (P = .4 in patients without diabetes and P = .8
in those with diabetes).
Discussion
This study has demonstrated that the oxidative stress
induced by CPB is greater in patients with diabetes
than in those without diabetes and that the inflammato-
ry reaction is qualitatively different in the 2 groups of
patients. Thus, whereas complement activation was
more prominent and neutrophil activation was main-
tained longer in patients with diabetes than in those
without, the increased production of cytokines seen in
patients without diabetes was completely blunted in
those with diabetes. Our study has also shown that
exogenous NO significantly reduces oxidative stress in
patients with diabetes and that it differentially affects
the inflammatory response to CPB both in patients with
and in those without diabetes. The clinical importance
of these findings and their relevance to understanding
the cause of oxidative stress and the regulatory mecha-
nism of production of inflammatory factors are dis-
cussed below.
Oxidative stress. Previous studies have demonstrat-
ed that oxygen-derived free radicals are generated dur-
ing CPB,18 that lipid peroxidation occurs during
CPB,17 and that pretreatment with antioxidants before
CPB minimizes lipid peroxidation.19 However, to our
knowledge, the present study is the first in reporting
that CPB-induced oxidative stress is approximately 2-
fold greater in patients with diabetes than in those with-
out diabetes, a factor that may contribute to a poorer
The Journal of Thoracic and
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Fig 5. Plasma elastase before, during, and after coronary
bypass graft surgery in patients without diabetes (A) and in
those with diabetes (B) receiving saline solution or nitroglyc-
erin (GTN). Values are expressed as means of 10 patients per
group and bars represent the SEM.
B
A
Fig 6. Plasma interleukin 8 (IL-8) before, during, and after
coronary bypass graft surgery in patients without diabetes
(A) and in those with diabetes (B) receiving saline solution or
nitroglycerin (GTN). Values are expressed as means of 10
patients per group and bars represent the SEM.
B
A
surgical outcome in the former group of patients.3 Yet
the results were not unexpected because previous
reports have suggested that persons with diabetes gen-
erate more free radicals4 and that their antioxidant
defenses are diminished.20
A novel finding in our study was that not only lipids
but also proteins are attacked by free radicals during
CPB. Our results contrast with those reported by
Pepper, Mumby, and Gutteridge.17 Like us, these
authors showed formation of lipid hydroperoxides but,
unlike us, they found no increase in protein carbonyls
during CPB. The reason for these conflicting results is
not clear, but differences in the type of patients investi-
gated (valve replacement in their study versus coronary
bypass graft surgery in ours) or the myocardial preser-
vation techniques (intermittent ischemic arrest in this
study versus cold cardioplegic arrest in their study)
may offer an explanation for the differences between
the 2 studies. However, both studies strengthen the
view that oxidative stress may be a mechanism by
which CPB exerts its undesirable effects and that
antioxidant interventions may represent a potential
therapeutic target.
The rapid formation of protein nitrotyrosine, an
index of peroxynitrite generation, even before the initi-
ation of CPB both in patients with and in those without
diabetes (Fig 3, A and B) suggests that the metabolism
of NO may play an important role in the modulation of
oxidative stress observed during cardiac surgery. This
thesis is further supported by the effects of GTN on
decreasing the production of protein nitrotyrosine in all
patients (Fig 3, A and B) and on reducing the formation
of lipid hydroperoxides (Fig 1, B) and protein car-
bonyls (Fig 2, B) in patients with diabetes. The effects
of GTN on oxidative stress may be due to the reduction
in the formation of endogenous NO seen in our study
(Table III) and also reported in the literature.21
Therefore, it appears that exogenous NO has potent
antioxidant properties in human beings and that its
clinical usefulness may be extended beyond the control
of the hemodynamic state.
Inflammatory reaction. The increase in CPB-
induced inflammatory reaction in terms of comple-
ment and neutrophil activation in patients with dia-
betes may be a contributory factor to the reported
higher operative mortality and greater rate of perioper-
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Fig 7. Plasma tumor necrosis factor-α (TNF-α) before, dur-
ing, and after coronary bypass graft surgery in patients with-
out diabetes (A) and in those with diabetes (B) receiving
saline solution or nitroglycerin (GTN). Values are expressed
as means of 10 patients per group and bars represent the SEM.
B
A
Fig 8. Plasma soluble E-selectin before, during, and after
coronary bypass graft surgery in patients without diabetes
(A) and in those with diabetes (B) receiving saline solution or
nitroglycerin (GTN). Values are expressed as means of 10
patients per group and bars represent the SEM.
B
A
ative complications in this group of patients undergo-
ing cardiac surgery.3 The cause of this reaction and the
pathophysiologic implication of the lack of increase in
proinflammatory cytokines in patients with diabetes
are unclear. A possible explanation may be that the
inflammatory reaction is initiated or facilitated by
oxidative stress. At first sight this thesis would appear
to be supported by our findings that oxidative stress is
greater in patients with diabetes than in those without
diabetes and by the reported correlation between com-
plement activation and oxidative stress during CPB.18
However, in our study the reduction in the CPB-
induced oxidative stress by GTN in patients with dia-
betes resulted in a partially corresponding decrease in
the CPB-induced inflammatory response. On the con-
trary, GTN increased plasma elastase (Fig 5, B) and
IL-8 (Fig 6, B), without affecting complement activa-
tion (Fig 4, B) and TNF-α (Fig 7, B). Therefore, results
do in fact contradict the thesis that there is a direct
relationship between the CPB-induced inflammatory
reaction and oxidative stress.
An alternative explanation for the specific inflamma-
tory reaction induced by CPB in patients with diabetes
is that the regulation of the genes coding for a variety
of inflammatory factors and their signal transduction
pathways may be altered in this group of patients. This
proposition is supported by the demonstration that pro-
tein kinase C is chronically activated in diabetic tis-
sues,22,23 which in turn may activate the stress/mitogen
protein kinase–associated transcription factor activator
protein–1.24 Our demonstration of higher complement
activation (Fig 4, B) with prolonged release of elastase
(Fig 5, B) in patients with diabetes would also support
this thesis. However, the validity of this thesis has to be
questioned in view of our findings that the release of
IL-8 and TNF-α was lower in patients with diabetes.
The diversity of these results may be owed to the
involvement of different gene transcription factors and
signal transduction mechanisms and to the fact that
these may be differently affected in patients who do
and do not have diabetes. This is an area that clearly
requires further investigation.
The results of the administration of exogenous NO on
the CPB-induced release of inflammatory factors seen
in the present study are also novel. The observed
increase in complement activation in patients without
diabetes (Fig 4, A) and the higher plasma elastase (Fig
5, B) and IL-8 (Fig 6, B) in patients with diabetes when
GTN was administered are indicative that exogenous
NO exacerbates the CPB-induced inflammatory reac-
tion. Since NO is known to possess anti-inflammatory
properties, the action of exogenous NO in promoting
inflammation may be explained by its effect in reducing
the formation of endogenous NO, as mentioned before.
Our results contrast with those of Seghaye and col-
leagues,25 who observed the inhibition of complement
activation by sodium nitroprusside. However, in con-
trast to our study, these investigators used sodium nitro-
prusside instead of GTN. In addition, their study was
carried out in children with congenital heart defects
instead of adults with coronary artery disease, and a
sodium nitroprusside dose ranging from 0.6 to 2.9 µg ·
kg–1 · min–1 was variably administered only during the
cooling and rewarming periods of extracorporeal circu-
lation. In our study, GTN was administered at the dose
of 1 µg · kg–1 · min–1 starting 10 minutes before the ini-
tiation of CPB and then for the next 4 hours, which
included the entire period of CPB. Indeed, the type of
NO donor and the time and dose of its administration
may be important factors in determining the effect of
these agents on the inflammatory cascade.
In the present study, GTN also reduced the formation
of TNF-α in patients without diabetes (Fig 7, A), and
this may suggest that the effect of exogenous NO on
inflammation is complex and dependent on the disease
state. The literature is also conflicting in that NO has
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Fig 9. Plasma thrombomodulin before, during, and after
coronary bypass graft surgery in patients without diabetes
(A) and in those with diabetes (B) receiving saline solution or
nitroglycerin (GTN). Values are expressed as means of 10
patients per group and bars represent the SEM.
B
A
been shown to inhibit26 and activate27,28 the production
of inflammatory cytokines. The understanding of this
effect is crucial to elucidate the dynamics and the clin-
ical potential of NO. Clearly, this topic also requires
further investigation.
The results on soluble E-selectin, an endothelial mol-
ecule that facilitates the recruitment of monocytes and
lymphocytes to the lesion site,29 showing that its plas-
ma values remained elevated for a longer period in
patients with diabetes than in those without diabetes
(Fig 8, A), are in agreement with our own data that the
inflammatory reaction induced by CPB is exacerbated
in patients with diabetes. However, at this point it could
also be speculated that the release of soluble E-selectin
into the plasma compartment may not be indicative of
parallel changes in the density and expression of the
molecule on the endothelium; instead, it may represent
a protective mechanism that allows the clearance of
these molecules from the cell surfaces, therefore limit-
ing leukocyte attachment and cell injury.30 As seen with
plasma elastase and IL-8, GTN also increased soluble
E-selectin in patients with diabetes (Fig 8, B). At first
sight, one might be tempted to conclude that the effect
in patients with diabetes would be proinflammatory.
However, using the above argument, if the elevation of
soluble E-selectin in plasma represents an increase of
the shedding of the molecule and not an increase of its
expression, then it should be concluded that the effect
of GTN is anti-inflammatory. Indeed, the latter thesis is
supported by the demonstration that shedding of mole-
cules from the endothelium may be influenced by a
number of factors,30 possibly including NO, as shown
by our own results. As discussed earlier, whether this
effect is due to the exogenous NO or to the inhibition
of production of endogenous NO by exogenous NO
also needs to be clarified. De Caterina and coworkers26
reported that NO significantly inhibits the expression
of vascular cell adhesion molecule 1 and soluble E-
selectin in lipopolysaccharide and cytokine-stimulated
human saphenous vein endothelial cells in vitro.
However, their findings do not completely elucidate the
mechanism of this effect, because the expression and
activity of endothelial and inducible NO synthases and
the levels of NO in the preparation were not studied.
Despite the different response to CPB and the infu-
sion of GTN between patients with and without dia-
betes, in terms of both oxidative stress and inflamma-
tory reaction, plasma thrombomodulin, a marker of
endothelial injury,16 was similar in the 2 groups of
patients and this was unaffected by GTN (Fig 9, A and
B). These results appear to strengthen the thesis that the
vascular endothelium is well equipped to withstand the
changes occurring during elective cardiac surgery and
that disruption of its integrity may require more severe
challenges.
Clinical implications. Our results have shown that
oxidative stress is greater in patients with diabetes than
in those without diabetes and that its reduction by NO-
donor agents may represent a potential target to
improve the clinical outcome in this group of patients
undergoing cardiac surgery. Our study, performed in a
selected reduced number of patients, was not designed
to investigate the clinical benefit of this therapy.
However, despite this, a shorter hospital stay (margin-
ally not significant) was seen in patients receiving
GTN. It should be conceded that the shorter hospital
stay was also observed in patients without diabetes, in
whom oxidative stress was unaffected by GTN, an
observation that would suggest that the action of GTN
in reducing oxidative stress may not be the sole mech-
anism responsible for the improved recovery.
This study has also demonstrated that GTN may
increase the release of some components of the inflam-
matory reaction induced by CPB both in patients with
diabetes and in those without diabetes. As a result and
despite the observed benefits in reducing oxidative
stress in patients with diabetes, caution should be exer-
cised regarding the use of NO donors, particularly
when treating patients with an underlying proinflam-
matory condition. Certainly, the elucidation of the
mechanisms underlying the above effects is a prerequi-
site for safer use of NO donors and for improvement of
the clinical outcome in cardiac surgery.
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